Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media containing 1% glycine does not support growth.
Engberg, J., On, S. L., Harrington, C. S., & Gerner-Smidt, P. (2000). Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. Journal of Clinical Microbiology, 38(1), 286–291.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, clinical sources (blood - CCUG) and animals
DNA G+C(%): 37-38
|
Lower T(℃): 25(neg)
Mid T(℃): 37(+)
High T(℃): 42(neg)
NaCl 0.5-2%: 2(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: Sens
|
cefoperazone: R(64)
cefoxitin: I(30)
|
gentamicin: Sens
spectinomycin: Sens
streptomycin: Var
|
erythromycin: Var
|
nalidixic-acid: S(30)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: Sens
tetracycline: Sens
|
|
rifampicin: Sens
|
chloramphenicol: Sens
metronidazole: Var
sulfamethoxazole: S(<4)
trimethoprim: Res
SXT: S(<8)
|
clindamycin: Var
|